ChEMBL ID: CHEMBL4297245
Mechanism of action: Amyloid-beta A4 protein disrupting agent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to DONANEMAB